Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment

Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment

Background and objective The efficacy of second or third-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients is low. The use of targeted drugs brings survival benefit for some patients. Apatinib, as a novel small molecule antiangiogenic drug, has demonstrated satisfactory antic...

Full description

Bibliographic Details
Main Authors: Xuemin WANG, Weihong ZHANG, Weijiao DU, Xinwei ZHANG, Xiubao REN, Shui CAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Apatinib
Efficacy
Safety
Survival analysis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.07

Similar Items